Institutional investors hold a majority ownership of LLY through the 65.71% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Pharmaceuticals: Major industry. Last, during the quarter ended June 2017, these large investors purchased a net $5.4 million shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
DODGE & COX Bought 6.0 Million shares of Eli Lilly and Co
RENAISSANCE TECHNOLOGIES LLC Bought 2.7 Million shares of Eli Lilly and Co
THE VANGUARD GROUP, INC. Bought 1.6 Million shares of Eli Lilly and Co